Suchergebnisse - "Wang, X"

PubPharm (191)

1

NTRK-rearranged spindle cell neoplasm : report of a case

enthalten in: Zhonghua bing li xue za zhi = Chinese journal of pathology | 2023

von Wei, X. | Wu, H. | Pu, X. | +3

2

Expert consensus on endocrine therapy of breast cancer (2023 edition)

enthalten in: Zhonghua yi xue za zhi | 2023

von Zhang, S. | Wang, X. | Jiang, Z.

3

Dose-dense paclitaxel plus carboplatin in combination with trastuzumab neoadjuvant versus standard adjuvant therapy in human epidermal growth factor receptor-2 positive and hormone receptor negative breast cancer : a prospective cohort study

enthalten in: Zhonghua zhong liu za zhi [Chinese journal of oncology | 2023

von Xiu, M. | Lu, Y. | Wang, X. | +11

4

Randomized phase II adjuvant trial to compare two treatment durations of icotinib (2 years versus 1 year) for stage II-IIIA EGFR-positive lung adenocarcinoma patients (ICOMPARE study)

enthalten in: ESMO open | 2023

von Lv, C. | Wang, R. | Li, S. | +23

5

Analysis of infection in B-cell lymphoma patients treated with BTK inhibitors

enthalten in: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi | 2023

von Wang, C. | Liu, H. | Li, L. | +11

6

Research Note : Developmental changes of glucose metabolism are associated with insulin signaling in goose embryo

enthalten in: Poultry science | 2023

von Wang, H. | Zhu, Y. | Yang, J. | +4

7

A single-arm, multicenter, phase II trial of osimertinib in patients with epidermal growth factor receptor exon 18 G719X, exon 20 S768I, or exon 21 L861Q mutations

enthalten in: ESMO open | 2023

von Villaruz, L. | Wang, X. | Bertino, E. | +11

8

Clinicopathological features of patients with RET fusion-positive non-small cell lung cancer

enthalten in: Zhonghua bing li xue za zhi = Chinese journal of pathology | 2023

von Tan, Q. | Ji, Y. | Wang, X. | +3

9

Final results of the global and Asia cohorts of KAMILLA, a phase IIIB safety trial of trastuzumab emtansine in patients with HER2-positive advanced breast cancer

enthalten in: ESMO open | 2022

von Wuerstlein, R. | Ellis, P. | Montemurro, F. | +13

10

Consensus for HER2 alterations testing in non-small-cell lung cancer

enthalten in: ESMO open | 2022

von Ren, S. | Wang, J. | Ying, J. | +30

ErratumIn: ESMO Open. 2022 Jun;7(3):100482. - PMID 35461023

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[20]